STOCK TITAN

Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Key Terms

j.p. morgan healthcare conference technical
An annual industry conference hosted by a major investment bank where healthcare and life-science companies present business plans, clinical progress and strategic updates to investors, analysts and partners. Think of it as a high-profile trade show or demo day for drugmakers and medical-device firms — information and announcements made there can change investor expectations and cause noticeable stock moves because attendees get early access to news, management access and deal-making activity.
webcast technical
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
510(k) clearance regulatory
A 510(k) clearance is a U.S. regulatory approval that lets a medical device be sold because it is shown to be substantially similar to an already-legal device; think of it as a passport saying the new product is close enough to a known item to enter the market without a full, lengthy review. For investors, 510(k) clearance signals faster, lower-cost market access and reduced regulatory risk compared with new, untested device pathways, which can materially affect timelines, costs and revenue prospects.
senior notes financial
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
revolving credit facility financial
A revolving credit facility is a type of loan that a business can borrow from whenever it needs money, up to a set limit. It’s like having a credit card for companies—allowing them to borrow, pay back, and borrow again as needed, providing flexibility for managing cash flow or funding short-term expenses.
form 4 regulatory
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
form 144 regulatory
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
8-k regulatory
An 8-K is a public report companies must file with the U.S. Securities and Exchange Commission to disclose major events or changes that shareholders should know about, such as leadership changes, mergers, financial surprises, or legal developments. It matters to investors because it acts like a breaking-news alert for a company’s health and prospects—providing timely facts that can affect stock value and investment decisions.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced its participation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026.

Stephan Tanda, President and CEO, will present at 11:15 a.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO and Gael Touya, President Aptar Pharma, will also be available.

A live audio webcast and presentation materials will be available in the "Investors" section of the Company's website at www.aptar.com.

About Aptar

Aptar is a global leader in drug delivery and consumer product, dispensing, dosing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Aptar Investor Relations Contact:

Mary Skafidas

mary.skafidas@aptar.com

+1 347 351 6407

Aptar Media Contact:

Katie Reardon

katie.reardon@aptar.com

+1 815 479 5671

Source: AptarGroup, Inc.

Aptargroup

NYSE:ATR

ATR Rankings

ATR Latest News

ATR Latest SEC Filings

ATR Stock Data

8.14B
64.88M
1.07%
96.35%
1.43%
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States
CRYSTAL LAKE